Monday, Dec 18, 2017
engineered enzymes for better healthcare

science-behind-research-and-development-150-smallEnzolve Technologies is an innovative, research-driven company utilizing its expertise in enzyme technology for a variety of specialist applications.

  • Enzolve develops and manufactures specially-designed enzymes for applications in healthcare, fine chemicals and life sciences markets.
  • Based on proprietary engineered enzymes Enzolve creates, develops and commercialises unique platform technologies and enzyme-based speciality products for clinical diagnostics and asymmetric synthesis. At the core of this development is the NeoScreenPak, a suite of tests for screening of babies for 7 out of the 11 most commonly screened inherited disorders.
  • Enzolve offers novel solutions for better visualisation of proteins following electrophoresis.
  • Enzolve also offers the provision of expert contract research services to assist companies or organisations with enzyme–related issues.

Disclaimer

Language Selection

Search

Latest News

Newborn Screening - First Steps into the marketplace
Irish technology to enable metabolic disorder screening among newborns in the developing world and remote locations... Read full article on the web Technology…

Read more...

Screen your baby’s health
Enzolve Technologies recently launched a novel newborn screening test for Phenylketonuria (PKU), an inherited metabolic disorder that results in severe mental…

Read more...

UCD campus company to begin production of newborn screening kits for international markets
Enzolve Technologies has recently secured substantial investment from Enterprise Ireland to allow them to begin immediate production of diagnostic screening kits…

Read more...